Algorithm to determine the outcome of patients with acute liver failure : a data-mining analysis using decision trees

スポンサーリンク

概要

• 論文の詳細を見る
• 2012-06-01

著者

• 持田 智

  埼玉医科大学 第三内科

• 持田 智

  埼玉医科大学 消化器内科・肝臓内科

• FUJIWARA Kenji

  Yokohama Rosai Hospital

• Fujiwara Kenji

  Division Of Gastroenterology And Hepatology Department Of Internal Medicine Faculty Of Medicine Sait

• Fujiwara Kenji

  横浜労災病院

• Mochida Satoshi

  埼玉医科大学 第3内科

• Inao M

  Gastroenterology And Hepatology Internal Medicine Saitama Medical School

• Fujimori Kenji

  Third Department Of Internal Medicine Saitama Medical School

• Nagoshi Sumiko

  Division Of Gastroenterology And Hepatology Department Of Internal Medicine Faculty Of Medicine Sait

• Oketani Makoto

  Department Of Digestive And Life-style Related Disease Kagoshima University Graduate School Of Medic

• Mochida Satoshi

  Department Of Applied Chemistry Faculty Of Engineering Osaka University

• Oketani Makoto

  Department Of Digestive And Life-style Related Disease Health Research Course Human And Environmenta

• Tsubouchi Hirohito

  Department Of Digestive And Life-style Related Disease Health Research Course Human And Environmenta

• Tsubouchi Hirohito

  Department Of Digestive And Life-style Related Disease Kagoshima University Graduate School Of Medic

• KAWAMURA Yoshihiro

  Life Sciences Solutions, IBM Japan

• Nagoshi Sumiko

  Department Of Gastroenterology And Hepatology Faculty Of Medicine Saitama Medical University

• Inao Mie

  Department Of Gastroenterology And Hepatology Faculty Of Medicine Saitama Medical University

• Nakayama Nobuaki

  Department Of Gastroenterology And Hepatology Faculty Of Medicine Saitama Medical University

• Kawamura Yoshihiro

  Life Sciences Solutions Ibm Japan

• Nagoshi Sumiko

  Department of Gastroenterology & Hepatology, Saitama Medical University, Japan

• TSUBOUCHI Hirohito

  Department fo Digestive and Lifestyle-related Disease, Health Research Human and Environnmental Scineces, Kagoshima University Graduate School of Medical and Dental Sciences

関連論文

• 免疫抑制・化学療法により発症するB型肝炎対策 : 厚生労働省「難治性の肝・胆道疾患に関する調査研究」班劇症肝炎分科会および「肝硬変を含めたウイルス性肝疾患の治療の標準化に関する研究」班合同報告
• Letter to the Editor(1)
• 劇症肝炎における新たな肝移植ガイドライン作成の試み
• PP310 ラット肝冷保存-同所性肝移植モデルにおける肝細胞及び類洞内皮細胞の障害と回復の過程について
• C型慢性肝炎に対する二重膜濾過血漿交換療法
• B型慢性肝炎の抗ウイルス療法 : 2. 劇症化 : そのメカニズムと治療の実際
• 劇症肝炎の原因と治療
• 肝胆膵疾患の漢方薬RCT (特集 漢方のRCT(その1))
• 劇症肝炎の現状と治療 (特集 肝炎診療を見直す)
• HBVキャリアからの重症化, 劇症化に対する治療
• 肝炎劇症化の機序
• 我が国における劇症肝炎, LOHFの実態
• 急性肝不全に対する生体肝移植の適応決定時期 - 劇症肝炎全国調査からの分析 -
• 急性肝不全診療ガイドライン (特大号 いま必要な診療ガイドライン--その使い方を中心に) -- (消化器)
• 基礎 肝線維化の分子医学 (特集 肝・胆・膵の分子医学--基礎と臨床)
• インターフェロン治療抵抗性C型慢性肝炎の病態と対策
• 4.肝移植後のprimary graft nonfunctionの成立機序と対策
• 劇症肝炎とラット肝不全モデルの相異似性
• プロトンポンプ阻害薬長期投与中に増大した胃底腺ポリープの検討
• Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis : Analysis of 698 patients seen between 1998 and 2003 enrolled in t
• Fulminant hepatitis and late onset hepatic failure in Japan : Summary of 698 patients between 1998 and 2003 analyzed by the Annual Nationwide Survey
• マロリー・ワイス症候群 (新版 処方計画法) -- (消化器疾患)
• SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
• Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice
• Plasma osteopontin levels in patients with fulminant hepatitis
• Angiopoietin/tie receptors system may play a role during reconstruction and capillarization of the hepatic sinusoids after partial hepatectomy and liver necrosis in rats
• ERK/MAPK-dependent PI3K/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells
• 中国産ダイエット用健康食品による急性肝障害
• 劇症肝炎及びLOHFにおける生体肝移植の適応と問題点
• PKC- and MAPK-independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation
• TT virus infection in cases of fulminant hepatic failure-evaluation by clonality based on amino acid sequence of hypervariable regions
• Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
• Possible mechanisms of elevation of serum transaminase levels during interferon-β therapy in chronic hepatitis C patients
• 1.インターフェロン(IFN)療法により無症候性キャリアとなった C型慢性肝炎症の例の病態と予後
• 1.広汎肝壊死を呈する疾患の病態:壊死と再生に関わる 肝構成細胞の相互作用
• 障害肝における類洞内皮細胞の増殖と肝再生不全
• プロスグクランジンによる急性肝不全の治療-臨床応用を目指した作用機序の検討-
• 劇症肝炎における肝再生機構と予後予測 (特別企画 再生医学) -- (肝)
• Translational research on HGF : A phase I/II study of recombinant human HGF for the treatment of fulminant hepatic failure
• Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma : a validation analysis
• Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment : a multivariate analysis of 411 patients at a single center
• 劇症肝炎 : わが国における問題点
• 肝炎ウイルスの臨床 急性肝炎,劇症肝炎の話題
• Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver
• 血管新生の分子機構 (特集 微小循環障害と消化器疾患)
• REVIEW 広汎肝壊死の機序--肝微小循環障害の面より (特集 劇症肝炎の分子機構と治療)
• 急性肝炎とその重症化予知 (特集 プライマリケアのための消化器疾患の診かた(2)肝・胆・膵疾患)
• Decreased expression of smooth muscle α actin in activated rat hepatic stellate cells at the S-phase of the cell cycle in vitro
• III.劇症肝炎2.病態解明
• 移植後肝障害の成立機序と対策
• 肝炎劇症化のメカニズム (特集 ウイルス肝炎の分子メカニズム)
• 肝疾患と血管 (特集 血管新生の分子機構と病態)
• 3.肝類洞内凝固を病態とする急性肝不全の治療
• 常習飲酒家C型慢性肝炎の病態
• 肝臓アレルギ- (特集:臓器アレルギ-の見直し)
• 急性肝不全患者に対する特殊組成アミノ酸の投与
• Impaired liver regeneration in acute liver failure : the significance of cross-communication of growth associated factors in liver regeneration
• Branched-chain amino acids, hepatocyte growth factor and protein production in the liver
• Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan
• Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men
• Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan
• THERAPEUTIC EFFICACY OF ISOSORBIDE DINITRATE FOR DYSPHAGIA AFTER ENDOSCOPIC INJECTION SCLEROTHERAPY FOR VARICES IN CIRRHOTIC PATIENTS
• C型肝炎治療薬としてのインターフェロン
• 消化器系における微小循環障害 (好中球と臓器障害)
• Indication criteria for liver transplantation for acute liver failure in Japan
• (肝臓領域)
• Rhodium-catalyzed Oxidative Coupling/Cyclization of Benzamides with Alkynes via C-H Bond Cleavage
• Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C
• The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma
• Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
• 第24回日本急性肝不全研究会 : 一般演題
• Proanthocyanidin derived from the leaves of Vaccinium virgatum suppresses platelet-derived growth factor-induced proliferation of the human hepatic stellate cell line LI90
• 第1回日本肝臓学会大会記録 : パネルディスカッション 肝不全の病態と予後
• 我が国における「急性肝不全」の概念，診断基準の確立：厚生労働省科学研究費補助金（難治性疾患克服研究事業）「難治性の肝・胆道疾患に関する調査研究」班，ワーキンググループ-1，研究報告
• Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
• 第23回日本急性肝不全研究会 : シンポジウム
• Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
• Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
• 第32回 日本肝臓学会総会記録 (4) : パネルディスカッション (6) 肝移植-実施に向けての医学的課題と将来
• Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
• Alcohol drinking patterns and the risk of fatty liver in Japanese men
• 我が国における「急性肝不全」の概念, 診断基準の確立 : 厚生労働省科学研究費補助金(難治性疾患克服研究事業)「難治性の肝・胆道疾患に関する調査研究」班, ワーキンググループ-1, 研究報告
• Novel classification of acute liver failure through clustering using a self-organizing map : usefulness for prediction of the outcome
• Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma
• The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome : a multicenter, open-label, explorative study
• タイトル無し
• Algorithm to determine the outcome of patients with acute liver failure : a data-mining analysis using decision trees
• A Multicenter Study to Clarify the Optimal HCV-RNA Negative Period during Combined Therapy with Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis Caused by HCV Genotype 2
• 急性肝不全に対する血液浄化療法の有効性評価 : 急性肝不全に対する人工肝補助療法の現状に関するアンケート調査報告
• 一般演題:1.劇症肝炎におけるGBV-C/HGVの関与
• A case of portal-systemic encephalopathy with rare shunt through superior mesenteric vein and left brachiocephalic vein: successfully treated with B-RTO
• 座談会　C型肝炎の抗ウイルス療法：日本肝臓学会の治療ガイドラインをめぐって
• Acute liver failure in Japan : definition, classification, and prediction of the outcome
• Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia : a randomized, open-label, phase II study
• Diagnostic criteria of acute liver failure : A report by the Intractable Hepato-Biliary Diseases Study Group of Japan
• Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
• Novel scoring system as a useful model to predict the outcome of patients with acute liver failure : Application to indication criteria for liver transplantation
• Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C : a nationwide multicenter cooperative study

もっと見る 閉じる

スポンサーリンク